Atropine Sulfate Injection, Solution
Product Images NDC 16729-512

This appears to be a description of a medication called Atropine Sulfate Injection, USP. It contains 0.4 mg per mL and is intended for intravenous, intramuscular, subcutaneous, intraosseous or endotracheal use. The usual dose is provided by the prescribing information. It comes in a 20 mL vial manufactured by Prameceutical Limited in Ahmedabad, India. The readable text is accompanied by some illegible text due to errors.*

Atropine Sulfate Injection, USP is a medication with a concentration of 0.4 mg per mL. It contains Atropine sulfate and benzyl alcohol, and is commonly administered via endotracheal use. The medication should be stored between 20°C to 25°C (68°F to 77°F) and needs to be discarded within 24 hours after initial use. The manufacturer of the medication is Accord Healthcare, Inc. The prescription information and dosage guidance should be followed for proper use. The medication is available in a multiple-dose vial, where each mL contains 0.3 mg Atropine sulfate (equivalent to 0.4 mg per mL). The pH level of the medication is adjusted with sulfuric acid, as necessary. The information regarding LOT and EXP or 2D matrix can be found on the packaging.*